Neurogene (NGNE) Return on Capital Employed Growth (3y) (2017 - 2026)
Neurogene (NGNE) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | Neurogene | 771.78 Mn | 771.78 Mn | - | 1,294.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,294.00 |
| Dec 31, 2025 | 1,278.00 |
| Sep 30, 2025 | 1,435.00 |
| Jun 30, 2025 | 1,334.00 |
| Mar 31, 2025 | 1,231.00 |
| Dec 31, 2024 | 252.00 |
| Sep 30, 2024 | -1,483.00 |
| Jun 30, 2024 | -1,529.00 |
| Mar 31, 2024 | -1,099.00 |
| Dec 31, 2023 | -2,556.00 |
| Sep 30, 2023 | -4,370.00 |
| Jun 30, 2023 | 496.00 |
| Mar 31, 2023 | -246.00 |
| Dec 31, 2022 | 2,021.00 |
| Sep 30, 2022 | 6,687.00 |
| Jun 30, 2022 | -2,140.00 |
| Dec 31, 2021 | 626.00 |
| Sep 30, 2021 | 1,443.00 |
| Jun 30, 2021 | 2,187.00 |
| Dec 31, 2020 | 3,229.00 |